We read with interest the paper by Boroojerdi et al (Reference Boroojerdi, Topper and Foltys1999). Our group found a shorter latency for motor evoked potentials (MEPs) to transcranial magnetic stimulation (TMS) in unmedicated people with schizophrenia of, on average, 2 ms compared with age- and gender-matched normal subjects (Reference Puri, Davey and EllawayPuri et al, 1996). In contrast, Boroojerdi et al (Reference Boroojerdi, Topper and Foltys1999) reported no such latency difference (in their group of medicated patients) and speculated that the presence of antipsychotic medication may have confounded their results. Indeed, our group has previously reported the effects of such medication on the latency and form of the inhibitory silent periods to TMS (Reference Davey, Puri and LewisDavey et al, 1997), which is known to occur as a result of activating superficial intracortical inhibitory interneurons, possibly GABAergic (Reference Davey, Romaiguère and MaskillDavey et al, 1994). Boroojerdi et al (Reference Boroojerdi, Topper and Foltys1999) found a longer latency of transcallosal inhibition to TMS in a group of medicated patients with schizophrenia but did not include a group of drug-naïve patients. It is clearly important to be able to differentiate between pathophysiological mechanisms resulting from schizophrenia and the actions of antipsychotic medication on the corticospinal system.